Antineoplastics/cetuximab/nivolumabInterstitial lung disease: 10 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1844卷 / 1期

关键词：

D O I：

10.1007/s40278-021-91498-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[31] CotrimoxazoleInterstitial lung disease in elderly patients: 10 case reports
Reactions Weekly, 2010, 1317 (1) : 19 - 19
[32] NivolumabInterstitial pneumonia and skin disorder: 2 case reports
Reactions Weekly, 2022, 1925 (1) : 406 - 406
[33] Antineoplastics/steroidsIneffectiveness and interstitial lung disease: case report
Reactions Weekly, 2022, 1906 (1) : 73 - 73
[34] Antineoplastics/folinic acidGastric burst, lung and abdominal sepsis: 3 case reports
Reactions Weekly, 2021, 1868 (1) : 79 - 79
[35] Antineoplastics/glucocorticoidsZygomycosis: 3 case reports
Reactions Weekly, 2012, 1412 (1) : 8 - 8
[36] Antineoplastics/pembrolizumabDeath: 2 case reports
Reactions Weekly, 2023, 1944 (1) : 104 - 104
[37] Antineoplastics/methylprednisoloneNeutropenia: 12 case reports
Reactions Weekly, 2020, 1802 (1) : 53 - 53
[38] Antineoplastics toxicitySuicide: 4 case reports
Reactions Weekly, 2021, 1838 (1) : 65 - 65
[39] Antineoplastics/epirubicinAlopecia: 20 case reports
Reactions Weekly, 2016, 1591 (1) : 30 - 30
[40] Antineoplastics/pegfilgrastimAortitis: 18 case reports
Reactions Weekly, 2023, 1963 (1) : 85 - 85

← 1 2 3 4 5 →